Nevirapine

Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor

NADAC/unit $0.1442

No Shortage Tier 1: 63.8% 7 Manufacturers 11 ANDAs

Covered Lives

Generic Manufacturers

AUROBINDO PHARMA LTDCIPLA LTDHETERO LABS LTD UNIT IIIMACLEODS PHARMACEUTICALS LTDMICRO LABS LTDMYLAN PHARMACEUTICALS INCSANDOZ INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Nevirapine drfinder.aiFind doctors who prescribe Nevirapine clinicalrx.aiClinical profile: Nevirapine rxnews.aiLatest news about Nevirapine

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.